The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine
Open accessAbstract
Neurodegenerative diseases (NDDs) are characterized by selective dysfunction and loss of neurons associated with pathologically altered proteins that deposit in the human brain but also in peripheral organs. These proteins and their biochemical modifications can be potentially targeted for therapy or used as biomarkers. Despite a plethora of modifications demonstrated for different neurodegeneration-related proteins, such as amyloid-β, prion protein, tau, α-synuclein, TAR DNA-binding protein 43 (TDP-43), or fused in sarcoma protein (FUS), molecular classification of NDDs relies on detailed morphological evaluation of protein deposits, their distribution in the brain, and their correlation to clinical symptoms together with specific genetic alterations. A further facet of the neuropathology-based classification is the fact that many protein deposits show a hierarchical involvement of brain regions. This has been shown for Alzheimer and Parkinson disease and some forms of tauopathies and TDP-43 proteinopathies. The present paper aims to summarize current molecular classification of NDDs, focusing on the most relevant biochemical and morphological aspects. Since the combination of proteinopathies is frequent, definition of novel clusters of patients with NDDs needs to be considered in the era of precision medicine. Optimally, neuropathological categorizing of NDDs should be translated into in vivo detectable biomarkers to support better prediction of prognosis and stratification of patients for therapy trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–237 of 237
Nakamura, K., Mori, F., Kon, T., Tanji, K., Miki, Y., Tomiyama, M., Kurotaki, H., Toyoshima, Y., Kakita, A., Takahashi, H., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0208-0 · Cited by 61
Kamada, M., Izumi, Y., Ayaki, T., Nakamura, M., Kagawa, S., Kudo, E., Sako, W., Maruyama, H., Nishida, Y., Kawakami, H., et al. (2013) · Neuropathology · doi:10.1111/neup.12051 · Cited by 57
Altered α‐synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains
Brudek, T., Winge, K., Rasmussen, N. B., Bahl, J. M. C., Tanassi, J. T., Agander, T. K., Hyde, T. M., & Pakkenberg, B. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13392 · Cited by 54
Hagen, M. C., Murrell, J. R., Delisle, M., Andermann, E., Andermann, F., Guiot, M. C., & Ghetti, B. F. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00481.x · Cited by 50
Nakamura, K., Mori, F., Kon, T., Tanji, K., Miki, Y., Tomiyama, M., Kurotaki, H., Toyoshima, Y., Kakita, A., Takahashi, H., et al. (2015) · Neuropathology · doi:10.1111/neup.12243 · Cited by 50
Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain
Aoki, N., Higashi, S., Kawakami, I., Kobayashi, Z., Hosokawa, M., Katsuse, O., Togo, T., Hirayasu, Y., & Akiyama, H. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0984-6 · Cited by 47
Iatrogenic Creutzfeldt‐Jakob Disease with Florid Plaques
Kretzschmar, H. A., Sethi, S., Földvari, Z., Windl, O., Querner, V., Zerr, I., & Poser, S. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00025.x · Cited by 44
Disease-Associated Prion Protein in Vessel Walls
Koperek, O., Kovács, G. G., Ritchie, D. L., Ironside, J. W., Budka, H., & Wick, G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64474-4 · Cited by 44
Tacik, P. M., Sánchez-Contreras, M., Rademakers, R., Dickson, D. W., & Wszołek, Z. K. (2015) · Neurodegenerative Diseases · doi:10.1159/000440840 · Cited by 41
Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age
Pletniková, O., Rudow, G. L., Hyde, T. M., Kleinman, J. E., Ali, S. Z., Bharadwaj, R. A., Gangadeen, S., Crain, B. J., Fowler, D. R., Rubio, A. I., et al. (2015) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000071 · Cited by 41
Kovács, G. G., van der Zee, J., Hort, J., Kristoferitsch, W., Leitha, T., Höftberger, R., Ströbel, T., Broeckhoven, C. V., & Matěj, R. (2015) · Neuropathology · doi:10.1111/neup.12233 · Cited by 39
Gouras, G. K., Willén, K., & Tampellini, D. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.004 · Cited by 39
Nelson, P. T., Kukull, W. A., & Frosch, M. P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d8db07 · Cited by 37
Protein Folding and Misfolding: Neurodegenerative Diseases
Kaptein, R., Ovádi, J., & Orosz, F. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7 · Cited by 36
TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation
Martinez‐Lage, M., Molina‐Porcel, L., Falcone, D., McCluskey, L. F., Lee, V. M. ‐., Deerlin, V. M. V., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0947-y · Cited by 34
Rohan, Z., Rahimi, J., Weis, S., Kapás, I., Auff, E., Mitrović, N., Liberski, P. P., Sikorska, B., Matěj, R., & Kovács, G. G. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1455-7 · Cited by 33
Nakamura, M., Murray, M. E., Lin, W.-L., Kusaka, H., & Dickson, D. W. (2014) · Europe PMC (PubMed Central) · Cited by 29
Detection of TDP‐43 oligomers in frontotemporal lobar degeneration–TDP
Kao, P. F., Chen, Y., Liu, X., DeCarli, C. S., Seeley, W. W., & Jin, L. (2015) · Annals of Neurology · doi:10.1002/ana.24431 · Cited by 29
Significance and limitation of the pathological classification of TDP ‐43 proteinopathy
Arai, T. (2014) · Neuropathology · doi:10.1111/neup.12138 · Cited by 29
Oligodendroglial Response in the Spinal Cord in TDP-43 Proteinopathy with Motor Neuron Involvement
Rohan, Z., Matěj, R., Rusina, R., & Kovács, G. G. (2014) · Neurodegenerative Diseases · doi:10.1159/000362929 · Cited by 29
Neuropathology of Neurodegenerative Diseases: A Practical Guide
(2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660 · Cited by 28
Berghoff, A. S., Trummert, A., Unterberger, U., Ströbel, T., Hortobágyi, T., & Kovács, G. G. (2015) · Neuropathology · doi:10.1111/neup.12192 · Cited by 25
Review: pathology of variant Creutzfeldt-Jakob disease.
Peden, A., & Ironside, J. W. (2004) · PubMed · Cited by 25
Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt–Jakob disease
Peden, A., Ritchie, D. L., Uddin, H. P., Dean, A. F., Schiller, K. A. F., Head, M. W., & Ironside, J. W. (2007) · Journal of General Virology · doi:10.1099/vir.0.81913-0 · Cited by 24
Patterns of Tau and α-Synuclein Pathology in the Visual System
Rahimi, J., Milenković, I., & Kovács, G. G. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-140485 · Cited by 23
Neuropathological Diagnostic Considerations in Hyperkinetic Movement Disorders
den Dunnen, W. F. A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00007 · Cited by 22
Thal, D. R., Zuchner, S. L., Gierer, S., Schulte, C., Schöls, L. J., Schüle, R., & Synofzik, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025050 · Cited by 21
Berger–Sieczkowski, E., Milenković, I., Venkataramani, V., Giera, R., Ströbel, T., Höftberger, R., Liberski, P. P., Auff, E., Wirths, O., Bayer, T. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141524 · Cited by 19
Kovács, G. G., Molnár, K., Keller, É., Botond, G., Budka, H., & László, L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248aa70 · Cited by 19
Molecular diagnosis of human prion disease
Quadrio, I., Perret‐Liaudet, A., & Kovács, G. G. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.576664 · Cited by 17
Espay, A. J., Spina, S., Houghton, D. J., Murrell, J. R., de Courten‐Myers, G. M., Ghetti, B. F., & Litvan, I. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.201608 · Cited by 17
The TMEM106B locus and TDP-43 pathology in older persons without FTLD
Dickson, D. W., Rademakers, R., Nicholson, A. M., Schneider, J. A., Yu, L., & Bennett, D. A. (2015) · Neurology · doi:10.1212/01.wnl.0000472918.79256.a9 · Cited by 17
Liberski, P. P., Hainfellner, J. A., Sikorska, B., & Budka, H. (2012) · PubMed · doi:10.5167/uzh-68570 · Cited by 12
Matěj, R., Botond, G., László, L., Kopitar‐Jerala, N., Rusina, R., Budka, H., & Kovács, G. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.004 · Cited by 11
Protein-Based Neuropathology and Molecular Classification of Human Neurodegenerative Diseases
Kovács, G. G., & Budka, H. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_11 · Cited by 8
Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia
Wöehrer, A., László, L., Finsterer, J., Stöllberger, C., Furtner, J., Rinner, W., Molnár, K., Budka, H., & Kovács, G. G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0965-9 · Cited by 7
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<224::aid-ana12>3.0.co;2-w
Cited by
Using machine learning approaches for multi-omics data analysis: A review
Reel, P. S., Reel, S., Pearson, E., Trucco, E., & Jefferson, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107739 · Cited by 903
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Mezzaroba, L., Alfieri, D. F., Colado Simão, A. N., & Vissoci Reiche, E. M. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.07.007 · Cited by 524
Autism genetics: opportunities and challenges for clinical translation
Vorstman, J. A. S., Parr, J. R., Moreno-De-Luca, D., Anney, R. J. L., Nurnberger Jr, J. I., & Hallmayer, J. F. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.4 · Cited by 463
What is the evidence that tau pathology spreads through prion-like propagation?
Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0488-7 · Cited by 384
Metadata
- Authors
- Kovacs, G.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-02-02
- Volume
- 17
- Issue
- 2
- Pages
- 189
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2272796193
- Cited by
- 321
- References
- 237
- FWCI
- 25.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.